Adolescent GLP-1 Usage Surges 600% Between 2020 and 2023
Doctors warn of potential risks from prolonged Ozempic (semaglutide) use, citing emerging data on long-term GLP-1 receptor agonist safety, according to Dr. Sheila Armstrong, an endocrinologist at the National Institutes ... Read More